Yahoo Web Search

  1. Ads

    related to: cancer, glioma

Search results

    • Small Business - The Brewton Standard | The Brewton Standard

      The Brewton Standard· 4 days ago

      Sapience Therapeutics Presents Positive Clinical and Biomarker Data from ST101 Phase 2 Study in GBM at ASCO 2024 in Oral Presentation PR Newswire TARRYTOWN, N.Y., June 1, 2024 -Data demonstrates durable responses across 3 cohorts of patients with

    • Small Business - Picayune Item | Picayune Item

      The Picayune Item· 4 days ago

      Results from Phase 1 dose escalation trial of BDTX-1535 in GBM patients demonstrated a favorable safety and tolerability profile, and encouraging anti-tumor activity and duration of treatment Initial data from Phase 0/1 “trigger” (“window of

  1. Ad

    related to: cancer, glioma
  1. Related searches

    brain cancer glioma